PyInvesting

Market research

PRTO Tidal Trust III

NYSE USD Other

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
19M
P/E ratio
Not available
Analyst target
1
Dividend yield
0.0%
Beta
Not available

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Proteon Therapeutics, Inc is currently in a long term downtrend where the price is trading 17.2% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.

Based on the above factors, Proteon Therapeutics, Inc gets an overall score of 1/5.